Evidence map›Paper›PMID 23027006›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2013

Laser capture microdissection for protein and NanoString RNA analysis.

Yelena Golubeva, Rosalba Salcedo, Claudius Mueller, Lance A Liotta, Virginia Espina

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molecular imaging of the kidney in lupus nephritis to characterize response to treatment.Translational research : the journal of laboratory and clinical medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yelena GolubevaNational Cancer Institute-Frederick/SAIC, Frederick, MD, USA.
Rosalba Salcedo
Claudius Mueller
Lance A Liotta
Virginia Espina
George Mason University · USScience Applications International Corporation (United States) · US

Funding

Implementation of phosphoprotein preservation technology for cancer biospecimensR33CA157403 · NCI · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2011 to 2013
$922k
Surrogate and Sentinal Technologies to Monitor Stability of Cancer PhosphoproteinR21CA125698 · NCI · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2008 to 2009
$330k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS R21 CA125698NCI NIH HHS R33 CA157403
6 · The paper itself

Abstract

Laser capture microdissection (LCM) allows the precise procurement of enriched cell populations from a heterogeneous tissue, or live cell culture, under direct microscopic visualization. Histologically enriched cell populations can be procured by harvesting cells of interest directly or isolating specific cells by ablating unwanted cells. The basic components of laser microdissection technology are (a) visualization of cells via light microscopy, (b) transfer of laser energy to a thermolabile polymer with either the formation of a polymer-cell composite (capture method) or transfer of laser energy via an ultraviolet laser to photovolatize a region of tissue (cutting method), and (c) removal of cells of interest from the heterogeneous tissue section. The capture and cutting methods (instruments) for laser microdissection differ in the manner by which cells of interest are removed from the heterogeneous sample. Laser energy in the capture method is infrared (810 nm), while in the cutting mode the laser is ultraviolet (355 nm). Infrared lasers melt a thermolabile polymer that adheres to the cells of interest, whereas ultraviolet lasers ablate cells for either removal of unwanted cells or excision of a defined area of cells. LCM technology is applicable to an array of applications including mass spectrometry, DNA genotyping and loss-of-heterozygosity analysis, RNA transcript profiling, cDNA library generation, proteomics discovery, and signal kinase pathway profiling. This chapter describes LCM using an Arcturus(XT) instrument for downstream protein sample analysis and using an mmi CellCut Plus® instrument for RNA analysis via NanoString technology.

Indexed as

Gene Expression ProfilingAnimalsBase SequenceBenzoxazinesColoring AgentsCryopreservationEar, InnerEosine Yellowish-(YS)HematoxylinLaser Capture MicrodissectionMiceMicrotomyMolecular Sequence DataOxazinesPapillomaParaffin EmbeddingBenzoxazinesColoring Agentscresyl violetEosine Yellowish-(YS)HematoxylinOxazinesProteinsRNA

Identifiers

PMID23027006
PMCPMC3766583
OpenAlexW205573107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.